<! html public "-//W3C//DTD HTML 4.01 Transitional//EN">

<html>
<head>
<meta name="Sperowider-ArchiveRoot" content="../../../../../">
<meta name="Sperowider-DocRoot" content="../../../">
<meta name="Sperowider-OriginalURL" content="http://www.erowid.org/archive/rhodium/chemistry/bromomethoxyamph.nichols.html">
<title>Nichols: Potential Psychotomimetics - Bromomethoxyamphetamines - [www.rhodium.ws]</title>
<link href="../styles.css" rel="stylesheet" type="text/css">
</head>

<body>
<div style="border:black solid 1px;">
<div style="border:white solid 1px; padding:.25em; color: white; font: 700 9pt arial,sans-serif; background-color: darkblue;">
This file is a part of the Rhodium site archive. This Aug 2004 static snapshot is hosted by Erowid<br>
as of May 2005 and is not being updated. <a href="../index.html" style="color:white;">&gt; &gt; Back to Rhodium Archive Index &gt; &gt; </a>
</div>
</div>
<div class="top">
<a href="../rhodium.html">[www.rhodium.ws]</a> [] <a href="index.html">[Chemistry Archive]</a>
<br><form method="get" action="http://www.erowid.org/cgi-bin/search/htsearch.php?method=and&restrict=www.erowid.org%2Farchive%2Frhodium%2F&words=barron"><input type="hidden" name="config" value=""><input type="hidden" name="restrict" value=""><input type="hidden" name="exclude" value=""><input type="text" size="29" name="words" value="">&nbsp;<input type="submit" value="Search"></form>
<div class="spacer">&nbsp;</div>
</div>

<div class="header">
<h2>Potential Psychotomimetics - Bromomethoxyamphetamines</h2>
<h4>Charles F. Barfknecht &amp; David E. Nichols<br>J. Med. Chem. 14(4), 370-372 (1971)</h4>
<p>HTML by Weedar &amp; Rhodium</p>
</div>

<div class="stdtxt">

<p>In the study of psychotomimetic amphetamines, 2,5-dimethoxy-4-methylamphetamine (DOM) is the
most potent compound yet discovered (50-150 times mecaline)<a href="bromomethoxyamph.nichols.html#refs"><sup>2</sup></a>. At least part of its
potency is related to the nature of the para substituent. In the light of Knoll's<a href="bromomethoxyamph.nichols.html#refs"><sup>3</sup></a>
studies on the psychotomimetic effects of <i>p</i>-bromo-methampethamine and its 
cross-tolerance to LSD, the synthesis and evaluation of bromomethoxyamphetamines appeared to
be a logical extension. Br has a comparable size, but different electronic character than 
Me. Kand and Green<a href="bromomethoxyamph.nichols.html#refs"><sup>4</sup></a> have recently demonstrated a correlation between the electronic
character of the ring and the hallucinogenic potency of the methoxylated amphetamines. The 
substitution of Br into various ring positions of methoxylated amphetamines allows for several
electronic arrangements.</p>

<h4>Chemistry</h4>


<div class="tbl right"><p><b>Table I</b><br>
Substitued 1-Phenyl-2-nitropropenes<br><br></p>

<table border="1" cellpadding="3">
<tr>
<td><b>R<sub>2</sub></b></td>
<td><b>R<sub>3</sub></b></td>
<td><b>R<sub>4</sub></b></td>
<td><b>R<sub>5</sub></b></td>
<td><b>R<sub>6</sub></b></td>
<td><div align="center"><b>Mp, �C</b></div></td>
<td><b>Yield</b></td>
</tr>
<tr>
<td>Br</td>
<td>H</td>
<td>H</td>
<td>OCH<sub>3</sub></td>
<td>H</td>
<td><div align="center">73-74.5</div></td>
<td><div align="right">61.8%</div></td>
</tr>
<tr>
<td>H</td>
<td>Br</td>
<td>OCH<sub>3</sub></td>
<td>H</td>
<td>H</td>
<td><div align="center">73-74</div></td>
<td><div align="right">45%</div></td>
</tr>
<tr>
<td>H</td>
<td>OCH<sub>3</sub></td>
<td>Br</td>
<td>H</td>
<td>H</td>
<td><div align="center">73-74.5</div></td>
<td><div align="right">36.8%</div></td>
</tr>
<tr>
<td>Br</td>
<td>H</td>
<td>OCH<sub>3</sub></td>
<td>OCH<sub>3</sub></td>
<td>H</td>
<td><div align="center">105-106</div></td>
<td><div align="right">59.4%</div></td>
</tr>
<tr>
<td>H</td>
<td>OCH<sub>3</sub></td>
<td>Br</td>
<td>OCH<sub>3</sub></td>
<td>H</td>
<td><div align="center">121-121.5</div></td>
<td><div align="right">46.8%</div></td>
</tr>
<tr>
<td>OCH<sub>3</sub></td>
<td>H</td>
<td>Br</td>
<td>OCH<sub>3</sub></td>
<td>H</td>
<td><div align="center">113.5-115</div></td>
<td><div align="right">57%</div></td>
</tr>
</table>
</div>

<p>The general synthetic route involved preparation of the appropriately
substituted benzaldehydes, condensation with EtNO<sub>2</sub> and reduction to the 
bromomethoxymethamphetamines. <strong>Tables I</strong> and <strong>II</strong> summarize the compounds which have been prepared.</p>
 <p>Attention is called to the report by Pandya and co-workers<a href="bromomethoxyamph.nichols.html#refs"><sup>5</sup></a> concerning the bromination
of <i>m</i>-hydroxybenzaldehyde. The product of this reaction is claimed to be 
3-hydroxy-4-bromobenzaldehyde; however the product which we isolated proved to be 
2-bromo-5-hydroxybenzaldehyde. This assignment was verified by NMR spectroscopy and chemical
conversion by O-methylation and permanganate oxidation to 2-bromo-5-methoxybenzoic acid. The
physical properties of this material agree with the literature values<a href="bromomethoxyamph.nichols.html#refs"><sup>6</sup></a>.</p>


<div class="tbl left"><p><b>Table II</b><br>
Bromomethoxyamphetamines, HCl salts<br><br></p>

<table border="1" cellpadding="3">
<tr>
<td><b>#</b></td>
<td><b>R<sub>2</sub></b></td>
<td><b>R<sub>2</sub></b></td>
<td><b>R<sub>2</sub></b></td>
<td><b>R<sub>2</sub></b></td>
<td><b>R<sub>2</sub></b></td>
<td><div align="center"><b>Mp, �C</b></div></td>
<td><b>Yield</b></td>
</tr>
<tr>
<td><strong>1</strong></td>
<td>Br</td>
<td>H</td>
<td>H</td>
<td>OCH<sub>3</sub></td>
<td>H</td>
<td><div align="center">151.5-153</div></td>
<td><div align="right">20%</div></td>
</tr>
<tr>
<td><strong>2</strong></td>
<td>H</td>
<td>Br</td>
<td>OCH<sub>3</sub></td>
<td>H</td>
<td>H</td>
<td><div align="center">210-213</div></td>
<td><div align="right">28.8%</div></td>
</tr>
<tr>
<td><strong>3</strong></td>
<td>H</td>
<td>OCH<sub>3</sub></td>
<td>Br</td>
<td>H</td>
<td>H</td>
<td><div align="center">161.5-163</div></td>
<td><div align="right">32%</div></td>
</tr>
<tr>
<td><strong>4</strong></td>
<td>Br</td>
<td>H</td>
<td>OCH<sub>3</sub></td>
<td>OCH<sub>3</sub></td>
<td>H</td>
<td><div align="center">214-215.5</div></td>
<td><div align="right">42%</div></td>
</tr>
<tr>
<td><strong>5</strong></td>
<td>H</td>
<td>OCH<sub>3</sub></td>
<td>Br</td>
<td>OCH<sub>3</sub></td>
<td>H</td>
<td><div align="center">221-222</div></td>
<td><div align="right">36.8%</div></td>
</tr>
<tr>
<td><strong>6</strong></td>
<td>OCH<sub>3</sub></td>
<td>H</td>
<td>Br</td>
<td>OCH<sub>3</sub></td>
<td>H</td>
<td><div align="center">198-199</div></td>
<td><div align="right">29.5%</div></td>
</tr>
</table>
</div>



 <p>The LAH reduction of 1-(bromomethoxyphenyl)-2-nitropropenes was complicated by the extreme ease
of debromination. Low temperatures and equimolar amounts of reagents prevented the debromination,
but resulted in poor yields of the bromomethoxyamphetamines.</p>

<img src="pictures/space/8x8.gif" width="710" height="8" border="0">


<div class="tbl right">
<p><b>Table III</b><br>
Biological Results<br><br></p>

<table border="1" cellpadding="3">
<tr>
<td><strong>Compound</strong></td>
<td><div align="center"><strong>Treshold<a href="bromomethoxyamph.nichols.html#notes"><sup>&alpha;</sup></a><br>
  dose</strong></div></td>
<td><strong>Action</strong></td>
</tr>
<tr>
<td><strong>1</strong></td>
<td><div align="center">25 mg/kg </div></td>
<td>Inactive</td>
</tr>
<tr>
<td><strong>2</strong></td>
<td><div align="center">9 mg/kg </div></td>
<td>CNS stimulation;<br>onset of amphetamine-type<br>toxicity at 18 mg/kg</td>
</tr>
<tr>
<td><strong>3</strong></td>
<td><div align="center">7.5 mg/kg </div></td>
<td>Mescaline-like</td>
</tr>
<tr>
<td><strong>4</strong></td>
<td><div align="center">25 mg/kg </div></td>
<td>Inactive</td>
</tr>
<tr>
<td><strong>5</strong></td>
<td><div align="center"><10 mg/kg></div></td>
<td>Mescaline-like with some deaths<br>at 10; inactive at 5 mg/kg</td>
</tr>
<tr>
<td><strong>6</strong></td>
<td><div align="center"><2.5 mg/kg></div></td>
<td>Mescaline-like;<br>effect much more profound than<br>that caused by 2.5 mg/kg of DOM</td>
</tr>
</table>
<a name="notes"></a><p><b>&alpha;</b> Dose at which action wasobserved; any compd<br>which does not show mescaline-like
effect at 25<br>mg/kg (the "effective" dose of mescaline) is<br>considered inactive. The treshold dose
of<br>3,4-dimethoxyamphetamine.HCl and DOM.HCl<br>
are 12.5 and 2.5 mg/kg, respectively.</p>
</div>

<h4>Biological Results</h4>

<p>The compounds were tested for an effect on a conditioned avoidance
response in male rats. The detailed procedure has been reported previously<a href="bromomethoxyamph.nichols.html#refs"><sup>7</sup></a>. The effects
were compared with those produced by mescaline, 3,4-dimethoxy- methamphetamine, DOM, and the 
CNS-stimulant dextroamphetamine. This assay gives an indication wether the compound possesses
stimulant action or one more like that of mescaline, 3,4-DMA, and DOM. <strong>Table III</strong> summarizes
the biological data. All the compounds which exhibited an effect similar to mescaline-type
compounds have the <i>p</i>-Br substituent<a href="bromomethoxyamph.nichols.html#refs"><sup>8</sup></a>. The data on the 2-bromo-5-methoxy
analog (<b>3</b>) must be considered tentative, since 2,5-dimethoxyamphetamine which does not
have a para substituent is active in humans but inactive in rats<a href="bromomethoxyamph.nichols.html#refs"><sup>9</sup></a>. A correlation
has been demonstrated between the degree of fluorescence and the psychotomimetic potency for
methoxylated amphetamines; no such relationship seems to exist for this series<a href="bromomethoxyamph.nichols.html#refs"><sup>10</sup></a>.
For example, <b>2</b> and <b>6</b> have nearly the same degree of fluorescence, but differ
widely in their biological effects. A detailed study of the pharmacology is in progress.</p>
<div class="exp">
<h3>Experimental<a href="bromomethoxyamph.nichols.html#refs"><sup>11</sup></a></h3>

<p>All substituted benzaldehydes have been reported previously
with the exception of 2,5-dimethoxy-4-bromobenzaldehyde and 3,5-dimethoxy-4-bromobenzaldehyde,
whose syntheses are described below.</p>

<p><b>3,5-Dimethoxy-4-bromobenzaldehyde</b></p>

<p>3,5-Dihydroxy-4-bromobenzoic acid (K & K Laboratories,
 Inc.) was di-O-methylated with Me<sub>2</sub>SO<sub>4</sub> in the usual manner: yield 78%
(EtOH-H<sub>2</sub>O); mp 249-250�C (lit.<a href="bromomethoxyamph.nichols.html#refs"><sup>12</sup></a> 249-50�). The acid chloride was obtained
by reaction with SOCl<sub>2</sub>. The crude product (mp 124-128�) was used in the next step
without further purification. The aldehyde was obtained by reduction of the acid chloride by
LiAlH(O-<i>tert</i>-Bu)<sub>3</sub> as described by Ho, <i>et al.</i><a href="bromomethoxyamph.nichols.html#refs"><sup>13 </sup></a>The crude 
aldehyde was recrystd from MeOH-H<sub>2</sub>O; yield 52%; mp 112-114�C.</p>

<p><b>2,5-Dimethoxy-4-bromobenzaldehyde</b></p>

<p>2,5-Dimethoxybenzaldehyde (66.5 g, 0.4 mole) was
dissolved in 300 ml of CH<sub>2</sub>Cl<sub>2</sub>. Anhyd SnCl<sub>4</sub> (115 g, 0.44 mole)
was added, followed by 64 g of Br<sub>2</sub> over a 1-hr period. The resulting soln was 
refluxed for 2 hr and stirred overnight at room temp. The orange suspension was poured over
500 g of ice, and the layers were sepd. The CH<sub>2</sub>Cl<sub>2</sub> layer was washed with
10% NaHCO<sub>3</sub> and H<sub>2</sub>O and dried (Na<sub>2</sub>SO<sub>4</sub>). After 
filtration the solvent was removed <i>in vacuo</i>, and the solid residue recrystd from 
MeOH-H<sub>2</sub>O to yield 64 g (66%) of the aldehyde, mp 132-133�. The structure was 
confirmed by the oxidation with MnO<sub>4</sub><sup>-</sup> to 2,5-dimethoxy-4-brombenzoic acid, mp 170�C
(lit.<a href="bromomethoxyamph.nichols.html#refs"><sup>14</sup></a> mp 170�C).</p>

<p><b>Substitued-1-phenyl-2-nitropropenes</b></p> <p>The substitued benzaldehydes were refluxed with
EtNO<sub>2</sub> and NH<sub>4</sub>OAc in AcOH as described by Gairaud and Lappin.<a href="bromomethoxyamph.nichols.html#refs"><sup>15</sup></a></p>

<p><b>Bromomethoxyamphetamine Hydrochlorides</b></p> <p>All amphetamines were prepared from the 
corresponding 1-phenyl-2-nitropropenes by LAH reduction.<a href="bromomethoxyamph.nichols.html#refs"><sup>16</sup></a></p>
</div>




<img src="pictures/space/8x8.gif" width="710" height="8" border="0">

</div>

<div class="refs">
	<a name="refs"></a>
	<h2>References</h2>
	<ol>
	<li><span class="oli">&nbsp;</span></li>
	<li><span class="oli">A.T. Shulgin, T. Sargent, and C. Naranjo, <strong><a href="../djvu/shulgins.djvu">Nature (London), 221, 537 (1969)</a></strong></span></li>
	<li><span class="oli">J. Knoll in "<strong>Amphetamines and Related Compounds</strong>", E. Costa and S. Garttini, Ed., Raven Press, New York, N. Y., 1970, p 761.</span></li>
	<li><span class="oli">S. Kang and J.P. Green, <strong>Nature (London), 226, 645 (1970)</strong></span></li>
	<li><span class="oli">K. C. Pandya, R. B. K. Pandya, and R. N. Singh. <strong>J. Indian Chem. Soc., 29, 363 (1952)</strong></span></li>
	<li><span class="oli">P. H. Beyer, <strong>Rec. Trav. Chim. Pays-Bas, 40, 621 (1921)</strong></span></li>
	<li><span class="oli">C. F. Barfknecht, J. M. Miles, and J. L. Leseney, <strong>J. Pharm. Sci., 59, 1842 (1970)</strong></span></li>
	<li><span class="oli">During the revision of this manuscript, Dr. A. T. Shulgin informes us that 4-bromo-2,5-dimethoxyamphetamine has a potency in humans greater than DOM and an effect similar to 3,4-methylenedioxyamphetamine; <a href="http://www.erowid.org/archive/rhodium/pdf/shulgin/shulgin.dob.pdf"><strong>Pharmacology 5, 103-107 (1971)</strong></a></span></li>
	<li><span class="oli">J. R. Smythies, <strong>Neurosci. Res. Program Bull., S, 79 (1970)</strong></span></li>
	<li><span class="oli">F. Antun, J. R. Smythies, F. Benington, R. D. Morin, C. F. Barfknecht, and D. E. Nichols, <strong>Experentia</strong>, <em>in press</em>.</span></li>
	<li><span class="oli">Melting points were taken on a Hoover Uni-Melt apparatus and are corrected. Where analyses are indicated only by symbols of the elements, anal. results obtained for those elements were within �0.4% of the theoretical values. NMR spectra for all compounds were obtained on a Varian Associates T-60 and are consistent with the assigned structures.</span></li>
	<li><span class="oli">H. Erdtman and B. Leopold, <strong>Acta Chem. Scand., 2, 34 (1948)</strong></span></li>
	<li><span class="oli">B. T. Ho, W. M. McIssac, R. An, L. W. Tansey, K. E. Walker, L. F. Englert, Jr., and M. B. Noel, <strong><a href="http://www.erowid.org/archive/rhodium/pdf/amph-analog-1.pdf">J. Med. Chem., 13, 26 (1970)</a></strong></span></li>
	<li><span class="oli">A. Luttringhaus and H. Gralheer, <strong>Justus Liebigs Ann. Chem., 550, 67 (1941)</strong></span></li>
	<li><span class="oli">C. B. Gairaud and G. R. Lappin, <strong><a href="nitrostyrenes.gairaud-lappin.html">J. Org. Chem., 18, 1-3 (1953)</a></strong></span></li>
	<li><span class="oli">L. F. Fieser and M. Fieser, "<strong>Reagents for Organic Synthesis</strong>", Wiley, New York, N. Y., 1967, p 581.</span></li>
	</ol>
</div>

</body>
</html>
